{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:16:10Z","timestamp":1793506570835,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"high-end talent project of science and technology innovation of Jiangxi \u201cdouble thousand plan\u201d","award":["jxsq2023201106"],"award-info":[{"award-number":["jxsq2023201106"]}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"crossref","award":["20204BCJ23017"],"award-info":[{"award-number":["20204BCJ23017"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81960061"],"award-info":[{"award-number":["81960061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05222-5","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:57:14Z","timestamp":1761040634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Runx1 drives cardiac fibrosis and heart failure through epigenetic activation of myofibroblasts in pressure overload-induced cardiac remodeling"],"prefix":"10.1186","volume":"25","author":[{"given":"Jun","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liao","family":"Geping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"5222_CR1","doi-asserted-by":"crossref","unstructured":"Shabani M, et al. Myocardial Fibrosis and Cardiomyopathy Risk: A Genetic Link in the MESA. Circ Heart Fail. 2023;16(9):e010262.","DOI":"10.1161\/CIRCHEARTFAILURE.122.010262"},{"issue":"6","key":"5222_CR2","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s12265-024-10527-5","volume":"17","author":"S Skarp","year":"2024","unstructured":"Skarp S, et al. Novel Genetic Variants Associated with Primary Myocardial Fibrosis in Sudden Cardiac Death Victims. J Cardiovasc Transl Res. 2024;17(6):1229\u201339.","journal-title":"J Cardiovasc Transl Res"},{"issue":"1","key":"5222_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41392-022-00972-6","volume":"7","author":"X He","year":"2022","unstructured":"He X, et al. Signaling cascades in the failing heart and emerging therapeutic strategies. Signal Transduct Target Ther. 2022;7(1):134.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"5222_CR4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/CIRCRESAHA.124.323800","volume":"135","author":"A Hinton Jr","year":"2024","unstructured":"Hinton A Jr, et al. Mitochondrial Structure and Function in Human Heart Failure. Circ Res. 2024;135(2):372\u201396.","journal-title":"Circ Res"},{"key":"5222_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21037\/sci-2023-019","volume":"10","author":"P Docshin","year":"2023","unstructured":"Docshin P, Bairqdar A, Malashicheva A. Interplay between BMP2 and Notch signaling in endothelial-mesenchymal transition: implications for cardiac fibrosis. Stem Cell Investig. 2023;10:18.","journal-title":"Stem Cell Investig"},{"key":"5222_CR6","doi-asserted-by":"crossref","unstructured":"Nikolov, A. and N. Popovski, Extracellular Matrix in Heart Disease: Focus on Circulating Collagen Type I and III Derived Peptides as Biomarkers of Myocardial Fibrosis and Their Potential in the Prognosis of Heart Failure: A Concise Review. Metabolites. 2022;12(4):297 .","DOI":"10.3390\/metabo12040297"},{"issue":"1","key":"5222_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","volume":"125","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis NG. The Extracellular Matrix in Ischemic and Nonischemic Heart Failure. Circ Res. 2019;125(1):117\u201346.","journal-title":"Circ Res"},{"key":"5222_CR8","doi-asserted-by":"crossref","unstructured":"Kurose, H., Cardiac Fibrosis and Fibroblasts. Cells, 2021. 10(7):1716.","DOI":"10.3390\/cells10071716"},{"issue":"7","key":"5222_CR9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/CIRCRESAHA.124.325402","volume":"136","author":"R Ghazal","year":"2025","unstructured":"Ghazal R, et al. Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure. Circ Res. 2025;136(7):773\u2013802.","journal-title":"Circ Res"},{"issue":"2","key":"5222_CR10","first-page":"99","volume":"43","author":"AS Samarakkody","year":"2020","unstructured":"Samarakkody AS, Shin NY, Cantor AB. Role of RUNX Family Transcription Factors in DNA Damage Response. Mol Cells. 2020;43(2):99\u2013106.","journal-title":"Mol Cells"},{"key":"5222_CR11","doi-asserted-by":"crossref","unstructured":"Seo, W., A. Nomura, and I. Taniuchi, The Roles of RUNX Proteins in Lymphocyte Function and Anti-Tumor Immunity. Cells. 2022; 11(19):3116.","DOI":"10.3390\/cells11193116"},{"key":"5222_CR12","doi-asserted-by":"crossref","unstructured":"Zhou, T., et al., Runt-Related Transcription Factor 1 (RUNX1) Promotes TGF-\u03b2-Induced Renal Tubular Epithelial-to-Mesenchymal Transition (EMT) and Renal Fibrosis through the PI3K Subunit p110\u03b4. EBioMedicine. 2018;\u00a031: 217\u2013225.","DOI":"10.1016\/j.ebiom.2018.04.023"},{"key":"5222_CR13","doi-asserted-by":"crossref","unstructured":"Dubey, S., et al., Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts. J Cell Physiol. 2022;237(4):2169-82.","DOI":"10.1002\/jcp.30684"},{"key":"5222_CR14","doi-asserted-by":"crossref","unstructured":"Huang, J., et al., RUNX1 regulates SMAD1 by transcriptionally activating the expression of USP9X, regulating the activation of hepatic stellate cells and liver fibrosis. Eur J Pharmacol. 2021; 903: 174137.","DOI":"10.1016\/j.ejphar.2021.174137"},{"key":"5222_CR15","doi-asserted-by":"crossref","unstructured":"Ni, T., et al., Dihydrolycorine Attenuates Cardiac Fibrosis and Dysfunction by Downregulating Runx1 following Myocardial Infarction. Oxid Med Cell Longev. 2021; 2021: 8528239.","DOI":"10.1155\/2021\/8528239"},{"key":"5222_CR16","doi-asserted-by":"crossref","unstructured":"Li X, et al. MicroRNA-101 Protects Against Cardiac Remodeling Following Myocardial Infarction via Downregulation of Runt-Related Transcription Factor 1. J Am Heart Assoc. 2019;8(23).","DOI":"10.1161\/JAHA.119.013112"},{"issue":"8","key":"5222_CR17","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/cvr\/cvaa034","volume":"116","author":"A Riddell","year":"2020","unstructured":"Riddell A, et al. RUNX1: an emerging therapeutic target for cardiovascular disease. Cardiovasc Res. 2020;116(8):1410\u201323.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"5222_CR18","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1038\/s41467-021-24607-6","volume":"12","author":"T Tabib","year":"2021","unstructured":"Tabib T, et al. Myofibroblast transcriptome indicates SFRP2(hi) fibroblast progenitors in systemic sclerosis skin. Nat Commun. 2021;12(1):4384.","journal-title":"Nat Commun"},{"issue":"18","key":"5222_CR19","doi-asserted-by":"publisher","first-page":"8277","DOI":"10.1073\/pnas.88.18.8277","volume":"88","author":"HA Rockman","year":"1991","unstructured":"Rockman HA, et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A. 1991;88(18):8277\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5222_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ymeth.2021.04.004","volume":"203","author":"P Sahadevan","year":"2022","unstructured":"Sahadevan P, Allen BG. Isolation and culture of adult murine cardiac atrial and ventricular fibroblasts and myofibroblasts. Methods. 2022;203:187\u201395.","journal-title":"Methods"},{"issue":"8","key":"5222_CR21","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.309202","volume":"119","author":"M Ackers-Johnson","year":"2016","unstructured":"Ackers-Johnson M, et al. A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes From the Adult Mouse Heart. Circ Res. 2016;119(8):909\u201320.","journal-title":"Circ Res"},{"issue":"3","key":"5222_CR22","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.7150\/thno.75871","volume":"13","author":"C Biederbick","year":"2023","unstructured":"Biederbick C, et al. Combined use of magnetic microbeads for endothelial cell isolation and enhanced cell engraftment in myocardial repair. Theranostics. 2023;13(3):1150\u201364.","journal-title":"Theranostics"},{"issue":"5","key":"5222_CR23","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/febs.14751","volume":"286","author":"G Chen","year":"2019","unstructured":"Chen G, et al. The RUNX1-ETO fusion protein trans-activates c-KIT expression by recruiting histone acetyltransferase P300 on its promoter. Febs j. 2019;286(5):901\u201312.","journal-title":"Febs j"},{"issue":"1","key":"5222_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1532\/IJH97.05075","volume":"82","author":"T Yamagata","year":"2005","unstructured":"Yamagata T, Maki K, Mitani K. Runx1\/AML1 in normal and abnormal hematopoiesis. Int J Hematol. 2005;82(1):1\u20138.","journal-title":"Int J Hematol"},{"key":"5222_CR25","doi-asserted-by":"crossref","unstructured":"Brower, G.L., et al., The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur J Cardiothorac Surg. 2006;\u00a030(4): 604\u2009\u2212\u200910.","DOI":"10.1016\/j.ejcts.2006.07.006"},{"key":"5222_CR26","doi-asserted-by":"crossref","unstructured":"L\u00f3pez, B., et al., Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nat Rev Cardiol. 2021;\u00a018(7): 479\u2013498.","DOI":"10.1038\/s41569-020-00504-1"},{"key":"5222_CR27","doi-asserted-by":"crossref","unstructured":"Sood, R., Y. Kamikubo, and P. Liu, Role of RUNX1 in hematological malignancies. Blood. 2017; 129(15): 2070\u20132082.","DOI":"10.1182\/blood-2016-10-687830"},{"key":"5222_CR28","unstructured":"Lie, A.L.M., et al., RUNX1 Dosage in Development and Cancer. Mol Cells. 2020;\u00a043(2): 126\u2013138."},{"issue":"2","key":"5222_CR29","first-page":"145","volume":"43","author":"A Yokota","year":"2020","unstructured":"Yokota A, et al. The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies. Mol Cells. 2020;43(2):145\u201352.","journal-title":"Mol Cells"},{"issue":"46","key":"5222_CR30","doi-asserted-by":"publisher","first-page":"16389","DOI":"10.1073\/pnas.1407097111","volume":"111","author":"W Kim","year":"2014","unstructured":"Kim W, et al. RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation. Proc Natl Acad Sci U S A. 2014;111(46):16389\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5222_CR31","doi-asserted-by":"crossref","unstructured":"Wang, Z.Y., et al., Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis. Sci Rep. 2021; 11(1): 19396.","DOI":"10.1038\/s41598-021-98806-y"},{"key":"5222_CR32","doi-asserted-by":"crossref","unstructured":"Koth, J., et al., Runx1 promotes scar deposition and inhibits myocardial proliferation and survival during zebrafish heart regeneration. Development. 2020; 147(8):dev186569.","DOI":"10.1242\/dev.186569"},{"issue":"1","key":"5222_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.117.028911","volume":"137","author":"CS McCarroll","year":"2018","unstructured":"McCarroll CS, et al. Runx1 Deficiency Protects Against Adverse Cardiac Remodeling After Myocardial Infarction. Circulation. 2018;137(1):57\u201370.","journal-title":"Circulation"},{"key":"5222_CR34","doi-asserted-by":"crossref","unstructured":"Zhang, D., et al., Runt-related transcription factor 1 (Runx1) aggravates pathological cardiac hypertrophy by promoting p53 expression. J Cell Mol Med. 2021; 25(16): 7867\u20137877.","DOI":"10.1111\/jcmm.16704"},{"issue":"31","key":"5222_CR35","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1038\/sj.onc.1203693","volume":"19","author":"AK Ghosh","year":"2000","unstructured":"Ghosh AK, et al. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300\/CBP transcriptional coactivators. Oncogene. 2000;19(31):3546\u201355.","journal-title":"Oncogene"},{"key":"5222_CR36","doi-asserted-by":"crossref","unstructured":"Bhattacharyya, S., et al., Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta. Arthritis Rheum. 2005; 52(4): 1248-58.","DOI":"10.1002\/art.20996"},{"issue":"8","key":"5222_CR37","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1053\/j.gastro.2018.02.015","volume":"154","author":"C Dou","year":"2018","unstructured":"Dou C, et al. P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts. Gastroenterology. 2018;154(8):2209-2221e14.","journal-title":"Gastroenterology"},{"issue":"4","key":"5222_CR38","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1111\/jcmm.14162","volume":"23","author":"R Rai","year":"2019","unstructured":"Rai R, et al. Acetyltransferase p300 inhibitor reverses hypertension-induced cardiac fibrosis. J Cell Mol Med. 2019;23(4):3026\u201331.","journal-title":"J Cell Mol Med"},{"key":"5222_CR39","doi-asserted-by":"crossref","unstructured":"Lee, Y.J., et al., Mechanism of transcriptional repression by TEL\/RUNX1 fusion protein. Mol Cells. 2004;17(2): 217\u2009\u2212\u200922.","DOI":"10.1016\/S1016-8478(23)13029-9"},{"key":"5222_CR40","doi-asserted-by":"crossref","unstructured":"Goodman, R.H. and S. Smolik, CBP\/p300 in cell growth, transformation, and development. Genes Dev. 2000;14(13):1553-77.","DOI":"10.1101\/gad.14.13.1553"},{"key":"5222_CR41","doi-asserted-by":"crossref","unstructured":"Rubio, K., et al., EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs. Int J Mol Sci. 2023;24(15):12302.","DOI":"10.3390\/ijms241512302"},{"issue":"3","key":"5222_CR42","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.apsb.2023.10.023","volume":"14","author":"R Liu","year":"2024","unstructured":"Liu R, et al. Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead. Acta Pharm Sin B. 2024;14(3):1009\u201329.","journal-title":"Acta Pharm Sin B"},{"key":"5222_CR43","doi-asserted-by":"crossref","unstructured":"Cheng M, et al. BRD4 promotes hepatic stellate cells activation and hepatic fibrosis via mediating P300\/H3K27ac\/PLK1 axis. Biochem Pharmacol. 2023;210:115497.","DOI":"10.1016\/j.bcp.2023.115497"},{"issue":"2","key":"5222_CR44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5483\/BMBRep.2022-0188","volume":"56","author":"H Kim","year":"2023","unstructured":"Kim H, et al. Therapeutic effects of selective p300 histone acetyl-transferase inhibitor on liver fibrosis. BMB Rep. 2023;56(2):114\u20139.","journal-title":"BMB Rep"},{"key":"5222_CR45","doi-asserted-by":"crossref","unstructured":"Kim, J., et al., The p300\/CBP Inhibitor A485 Normalizes Psoriatic Fibroblast Gene Expression In Vitro and Reduces Psoriasis-Like Skin Inflammation In Vivo. J Invest Dermatol. 2023;143(3): 431\u2013443e19.","DOI":"10.1016\/j.jid.2022.09.004"},{"key":"5222_CR46","doi-asserted-by":"crossref","unstructured":"Rai, R., et al., A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis. Epigenetics. 2017;12(11):1004\u20131013.","DOI":"10.1080\/15592294.2017.1370173"},{"key":"5222_CR47","doi-asserted-by":"crossref","unstructured":"Strachowska M, Robaszkiewicz A. Characteristics of anticancer activity of CBP\/p300 inhibitors - Features of their classes, intracellular targets and future perspectives of their application in cancer treatment. Pharmacol Ther. 2024;257.","DOI":"10.1016\/j.pharmthera.2024.108636"},{"key":"5222_CR48","doi-asserted-by":"crossref","unstructured":"Gil H, et al. Defining the timeline of periostin upregulation in cardiac fibrosis following acute myocardial infarction in mice. Sci Rep. 2022;12(1):21863.","DOI":"10.1038\/s41598-022-26035-y"},{"key":"5222_CR49","doi-asserted-by":"crossref","unstructured":"Li, L., Q. Zhao, and W. Kong, Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol, 2018. 68\u201369: p. 490\u2013506.","DOI":"10.1016\/j.matbio.2018.01.013"},{"issue":"3","key":"5222_CR50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1161\/CIRCRESAHA.107.149047","volume":"101","author":"T Oka","year":"2007","unstructured":"Oka T, et al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res. 2007;101(3):313\u201321.","journal-title":"Circ Res"},{"issue":"12","key":"5222_CR51","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1161\/CIRCRESAHA.116.308643","volume":"118","author":"H Kaur","year":"2016","unstructured":"Kaur H, et al. Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice. Circ Res. 2016;118(12):1906\u201317.","journal-title":"Circ Res"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05222-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:57:22Z","timestamp":1761040642000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05222-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5222"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05222-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods are reported in accordance with ARRIVE guidelines. The animal study protocol (2021-12-002) was approved by the Institutional Review Board of the Animal Care and Use Committee of First Affiliated Hospital of Nanchang University, Jiangxi, China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods are reported in accordance with ARRIVE guidelines. The animal study protocol (2021-12-002) was approved by the Institutional Review Board of the Animal Care and Use Committee of First Affiliated Hospital of Nanchang University, Jiangxi, China. Clinical trial number: not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"746"}}